AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
CHARLES TOWN, W.Va., Dec. 3 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), developers of state of the art electronic devices for diabetic peripheral neuropathy, Molluscum Contagiosum, and MRSA announces record profits for October 2007.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
"Corporate profits increased by 100% over October 2006," said Daena Carter, CFO of RBRM. "Full disclosure will be released on our annual report in January 2008."
"With the expected release of several MRSA related products in our Molluscum line in the first quarter of 2008 and the expected release of a unique peripheral neuropathy diagnostic device in the second quarter of 2008; we expect to continue our pattern of growth," according to David B. Phillips, Ph.D., CEO of RBRM, and inventor of the company's unique products.
For more information visit: http://www.rebuildermedical.com/, http://www.molluscum.com/.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created ...